Conclusion The theoretical basis for Hammesfahr's vasodilation treatment for stroke clashes with current knowledge about stroke physiology. In fact, the prevailing current belief is that such treatments should worsen stroke outcome, not improve it. I believe that vasodilation treatment for stroke patients should be done only as part of an approved peer-reviewed protocol that includes informed consent about the treatment's experimental status and possible risks. Because of the potential risk, I doubt that an institutional review board would permit such a study unless animal studies can demonstrate that the treatment is safe and potentially useful.
The court said they were wrong. They tried to prove it and they lost in court. It is just that simple. I guess they can say anything they want and you can believe it if you choose. Bottom line is that Dr. Hammesfahr beat them with facts. His method is approved by Medicare - "Fully Approved".
And FWIU Doctor Hammesfahr, using his treatment, has achieved success with patients declared untreatable. Seems to me that perhaps the "current knowledge about stroke physiology" could use some improvement?